policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
Frustration mounts over opioid shortage
Drug shortages and discontinuations are nothing new to veterinary medicine.
JAVMA news
In Short
Specialties proposed, ranitidine drugs contaminated, national disease list drafted
JAVMA news
In Short
AVMA joins well-being group, horse sedative approved, electronic health certificates allowed
JAVMA news
AABP calls for pain control during horn removal
Cattle should receive pain control drugs during and after horn or horn bud removal, according to the American Association of Bovine Practitioners.
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
JAVMA news
Updated Ag Guide expands on pain management
The Ag Guide is a primary reference for agricultural animal care at research institutions, and recent updates strengthen calls for use of pain…